The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  September 2018 Next

MedChemComm

EFMC Journal

Read more

MedChemWatch

EFMC e-newsletter

Read more

EFMC-Young Scientists Network

Building a strong network at the very early stage in your career is crucial. Therefore, EFMC decided to create a new network for young scientists: the EFMC-Young Scientists Network

The aim of the EFMC-YSN is to inspire, connect and provide opportunities to medicinal chemists and chemical biologists under the age of 35 by:

  • holding dedicated events & competitions
  • offering awards to best PhDs & Post-docs
  • funding grants and scholarships to attend EFMC organised and sponsored events
  • providing a forum to exchange, seek advices and mentoring

Shaping itself it into a usefull tool, custom-made to your needs and managed by young scientists, for young scientists.

Join the EFMC-YSN now and get access to the content as it becomes available in the following weeks/months.

Questions? Reach out to us at ysn@efmc.info


Joint EFMC|EuChemS workshop - Parkinson’s disease: causes & cures – registration open

A workshop co-organised by the European Chemical Society (EuChemS) and the European Federation of Medicinal Chemistry (EFMC), and chaired by Member of the European Parliament Pavel Poc will look at Parkinson’s disease: causes and cures at the European Parliament (Brussels, Belgium)on 8 November 2018.

Registration is now open! Click here to regsiter and for further information (outline, programme, speakers, abstracts).

Parkinson’s is a progressive neurodegenerative disorder having no known cause, typically with onset later in life. Prevalence in the 60-69-year-old population is estimated to be approximately 1.0%, rising to 2.7% in those over 80. There are more than one million people living with Parkinson’s today in Europe; with an ageing population this figure is forecast to double by 2030. The condition is characterised by difficulty in moving and tremor, as well as psychiatric issues. It leads to a progressive reduction in the quality of life and those affected require increasing care. This imposes a significant socioeconomic burden which currently amounts to €13.9 billion of healthcare expenditure annually.

There is no cure for Parkinson’s yet. The current ‘gold standard’ medication, levodopa, was introduced in 1967, with few new therapeutic agents being registered since then. As such, there is an urgent need to develop new and better treatments. However, despite clinical strategies remaining largely unchanged over the past 50 years, our understanding of the disease mechanisms in Parkinson’s has advanced dramatically, revealing novel druggable targets. Hence, the disorder is in need of extra investment to translate these exciting opportunities into life changing therapies for patients.

In addition to genetic mutations, a potential risk factor for Parkinson’s disease is exposure to some toxins or herbicides, including diquat. In 2015, the European Food Safety Agency (EFSA) declared the herbicide to be potentially harmful and indicated it should be banned. The European Commission did not submit the proposal to the ScoPAFF, and invited EFSA to revise its opinion.

The workshop aims to look at the causes of Parkinson’s disease as well as possible ways forward, both clinically, but also on a political level, notably through the upcoming Horizon Europe research framework programme.


EFMC is supporting the International Year of the Periodic Table of Chemical Elements 2019 (IYPT2019)

EFMC is supporting the new EuChemS Periodic Table, depicting the issue of element scarcity on the occasion of the upcoming International Year of the Periodic Table of Chemical Elements 2019 (IYPT2019). The EFMC shares their hope that this image will lead to reflection, and ultimately action, that it will raise awareness of the threat this poses and also hope to see it have an impact on policy, education and on individual actions.

The Periodic Table has a lot of potential, and could be disseminated in an effective way by providing schools, universities and wider networks with it, whether in hard copies or electronically. Please feel free to also use it to print onto various merchandise items, such as T-shirts, bags, ….

The Periodic Table is now freely downloadable in high resolution on EuChemS’ website. The work is licensed under the Creative Commons Attribution NoDerivs CC BY-ND.

Support notes, which explain in more detail how the Periodic Table has been designed, and which also include some questions for students, will soon be available for download on our website. Versions in other languages are to be developed.

We strongly encourage you to share it as widely as possible (website, social media, …).

If you have any questions, please contact the EuChemS Secretariat at: secretariat@euchems.eu


Photo Competition - Reality of Medicinal Chemistry - Winners announced!

The Communication Team is happy to announce the winner and two runners-up of the 2018 Photo Competition "Reality of Medicinal Chemistry"!

We are thrilled by the success of this first edition of the competition, which gathered more than 78 applications, 1500 online votes during the first round and around 200 votes at the EFMC-ISMC 2018 for the final selection!

Congratulations to all the contestants for their participation! All the pictures will be published in the 2019 edition of the EFMC Yearbook, and will be used on various EFMC communication supports.

Looking forward to receiving your applications for the 2019 edition of the photo contest, to be announced soon!

Have a look at all the pictures here!


The 10 EFMC Best Poster Prizes have been awarded during the EFMC-ISMC

The EFMC is pleased to announce the recipients of the 10 "EFMC Best Poster Prizes"

 

  • Lisa Barbaro, Monash University, AU
  • Emma Evertson, AstraZeneca, SE
  • Niels Hauwert, Vrije Universiteit Amsterdam, NL
  • Jan Hellmann, FAU Erlangen-Nuremberg, DE
  • Christina Lamers, University of Basel, CH
  • Grant McGonagle, GlaxoSmithKline,UK
  • Janez Mravljak, University of Ljubljana, SI
  • Vlad Pascanu, University of Zurich, CH
  • Elisabeth Rexen Ulven, University of Southern Denmark, DE
  • Céline Ronin, NovAliX, FR

Each poster prize consist of a diploma, a 200€ prize and a one year free subscription to MedChemComm, the official EFMC journal.

The prizes have been delivered at the occasion of the EFMC-ISMC 2018, which took place in Ljubljana, Slovenia on September 2-6, 2018

Congratulations to all the 10 worthy candidates!

Photographer - Fabien Venturi
Contact: venturifab@yahoo.fr


MedChemComm


M T W T F S S
27 28 29 30 31 01 02
03 04 05 06 07 08 09
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
01 02 03 04 05 06 07
All events   |  Future events

Job portal

27/04/2018
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck